Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 May 5;174:348–368. doi: 10.1016/j.addr.2021.04.027

Figure 3.

Figure 3.

Overview of EV characterization techniques and their capabilities. AFM: atomic force microscopy, cryo-EM: cryogenic electron microscopy; DLS: dynamic light scattering, ELISA: enzyme-linked immunosorbent assay, FCM: flow cytometry; IB: immunoblotting; IFCM: imaging flow cytometry; LC-MS: liquid chromatography mass spectrometry; MRPS: microfluidic resistive pulse sensing; MS: mass spectrometry; MS/MS: tandem mass spectrometry; NFCM: nanoflow cytometry; NGS: next-generation sequencing; NTA: nanoparticle tracking analysis; qPCR: quantitative polymerase chain reaction; SEM: scanning electron microscopy; SP-IRIS: Single-particle interferometric reflectance imaging sensing; TEM: transmission electron microscopy; TRPS: tunable resistive pulse sensing.